BAA FY26C3AP4: a cross-species immune organ chip reference framework for regulatory evaluation of vaccine and antiviral medical countermeasures = EO 14398
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00083
- Awardee
-
Board Of Regents Of Nevada System Of Higher Education UEI WLDGTNCFFJZ3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,500,000
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 15% obligated
-
- $1,500,000.00 Current, with exercised options
- $9,900,000.00 Potential, with all options
- Completion date 1% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Reno, NV 89557, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $9.9 million definitive contract to Board of Regents of Nevada System of Higher Education, operating as University of Nevada, Reno, for development of a cross-species immune organ chip reference framework for regulatory evaluation of vaccine and antiviral medical countermeasures on September 30, 2026, with completion by September 29, 2030.
The award responds to BAA FY26C3AP4, issued under Executive Order 14398 as part of the FDA's Advanced Research and Development of Regulatory Science initiative. The solicitation, posted November 21, 2025 with amendments through January 16, 2026, sought basic and applied research advancing regulatory science across three charge areas: modernizing development and evaluation of FDA-regulated products, strengthening post-market surveillance and labeling, and invigorating public health preparedness and response. The work is classified under NAICS 541714 (Research and Development in Biotechnology) and PSC AJ11 (General Science and Technology R&D Services). Place of performance is Reno, Nevada. The contract carries firm fixed price terms and no set-aside restriction. Multiple awards were anticipated under this BAA, with the government expressing a preference for cost-reimbursement contract types across the portfolio.
Quick answers
Who was awarded contract 75F40126C00083?
75F40126C00083 was awarded to Board Of Regents Of Nevada System Of Higher Education by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00083 worth?
The government has obligated $1,500,000 on 75F40126C00083. Its potential value, with all options, is $9,900,000.
Was contract 75F40126C00083 competed?
The extent of competition for 75F40126C00083 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award